Company News in the Life Science Industry

»

Reset 

Bone Therapeutics SA : Reports strong interim results from ALLOB® Phase IIA spinal fusion study

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Bone Therapeutics S. A.

ABLYNX ANNOUNCES WARRANT EXERCISE

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Ablynx N.V.

Sandoz proposed biosimilar adalimumab matches reference biologic in terms of efficacy and safety in long-term study

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Novan Therapeutics

Terveystalo is planning an initial public offering and a listing on Nasdaq Helsinki Ltd

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Hisamitsu Pharmaceutical Co., Inc.

Summit Announces Underwritten Public Offering of 1,459,000 ADSs to Raise USD17.5 Million Before Expenses

Read more ››
By: Nasdaq / GlobenewsWire - 14 Sep 2017
Related companies:  Summit Therapeutics plc | Summit Medical Products, Inc. | Great Summit Co., Ltd. | Summit Biosciences Inc.

Thermoplastic Elastomers Market will grow at 6% CAGR to exceed $20bn by 2023: Global Market Insights, Inc

OCEAN VIEW, Del., Sept. 13, 2017 /PRNewswire-iReach/ -- Global Thermoplastic... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017

BiondVax Announces Pricing of Public Offering of American Depositary Shares

NESS ZIONA, Israel, Sept. 13, 2017 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV, TASE: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, announced today that it has priced an underwritten public... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  BiondVax Pharmaceuticals Ltd.

Veloxis Pharmaceuticals, Inc., Appoints Ulf Meier-Kriesche, MD, as Chief Scientific Officer

COPENHAGEN, Denmark, Sept. 13, 2017 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) is pleased to announce that Veloxis Pharmaceuticals, Inc. has hired Ulf Meier-Kriesche, MD, to serve as its Chief Scientific Officer. In this role, Dr. Meier-Kriesche will oversee the Company's regulatory... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Veloxis Pharmaceuticals A/S

Young America Capital Successfully Assisted Pleuratech in Entering Into an Exclusive Worldwide License Agreement With Merit Medical

NEW YORK, Sept. 13, 2017 /PRNewswire/ -- Young America Capital (YAC) is pleased to announce that it has successfully assisted Pleuratech in entering an exclusive worldwide license agreement with Merit Medical for... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Merit Medical Systems, Inc.

Entegris Launches Oktolex(TM) Membrane Technology To Improve Yield In ArF, KrF, And EUV Lithography For Logic, DRAM, And 3D NAND Devices

BILLERICA, Mass., Sept. 13, 2017 /PRNewswire/ -- Entegris Inc. (NASDAQ: ENTG), a leading specialty materials provider, announced at SEMICON(®) Taiwan today, the availability of its innovative Oktolex(TM) membrane technology... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Entegris Inc

PTFE Membrane Market by Type, Application And Region - Global Forecast to 2021

NEW YORK, Sept. 13, 2017 /PRNewswire/ -- "The PTFE membrane market is projected to grow at a CAGR of 7.7% in terms of value during the forecast period"

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Avanti Hospitals Names Gerald Clute as CEO of East Los Angeles Doctors Hospital

LOS ANGELES, Sept. 13, 2017 /PRNewswire/ -- Avanti Hospitals announces the appointment of Gerald (Jerry) Clute as CEO of East Los Angeles Doctors Hospital (ELADH).

Read more ››
By: PR Newswire Association LLC. - 14 Sep 2017

Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis

CALGARY, Sept. 13, 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has filed its unaudited interim Consolidated Financial Statements and Management's Discussion & Analysis for the quarter ended July 31, 2017 and related Management's... Read more ››

By: PR Newswire Association LLC. - 14 Sep 2017
Related companies:  Resverlogix Corp.

Carevature's Dreal(TM) Lumbar Decompression System Shows Enhanced Foraminotomy Efficiency, With Reduced Spinal Instability and Patient Strain in Minimally Invasive Cases

TEL AVIV, Israel, Sept. 13, 2017 /PRNewswire/ -- Carevature Medical Ltd., developer of advanced orthopedic and neurological surgery solutions, announces the preliminary clinical results of its Dreal(TM) spinal decompression and bone removal system. The results will be given in an oral presentation... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2017

BiondVax Announces Public Offering of American Depositary Shares

NESS ZIONA, Israel, September 13, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2017

Eyemart Express Launches Exclusive Online Shopping

DALLAS, Sept. 13, 2017 /PRNewswire/ -- Eyemart Express, a nationally recognized Top 10 optical retailer, has launched an exclusive online shopping experience for its existing customers with a valid prescription.

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2017

Orexigen Therapeutics to Provide Business Update at the 2017 Cantor Fitzgerald Global Healthcare Conference

SAN DIEGO, Sept. 13, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management will present at the 2017 Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 27(th), at 1:35 PM PDT (4:35 PM EDT).

Read more ››
By: PR Newswire Association LLC. - 13 Sep 2017
Related companies:  Orexigen Therapeutics, Inc.

Final Five Unpublished Vascular Clinical Trial Results Announced At VIVA 17

LAS VEGAS, Sept. 13, 2017 /PRNewswire-USNewswire/ -- VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the final... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2017

BioAmber Inc. Receives Notice of Non-Compliance from the NYSE

MONTREAL, Sept. 13, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA, TSX: BIOA) announced today that the New York Stock Exchange (NYSE) has notified the Company that it is no longer in compliance with NYSE listing standards because the price of its common stock has fallen below the NYSE's share... Read more ››

By: PR Newswire Association LLC. - 13 Sep 2017
Related companies:  BioAmber Inc.

New Five-Year Gender Subset Data from the Medtronic Engage Registry Presented in VIVA Late Breaking Trials

Read more ››
By: Nasdaq / GlobenewsWire - 13 Sep 2017
Related companies:  Medtronic Plc
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23 24  25 »

Explore our database of over 40,000 companies